ResultsIQ

ResultsIQ › Latest results › Shalby Limited

Shalby Limited Q4 FY26 earnings call summary

NSE: SHALBY · BSE: 540797

Earnings call of 29 May 2026, summarised by AI from the filing.

Occupancy seen north of 50% next year; hospital and pharma growth at minimum 15% CAGR long term without significant capex.

Key takeaways

  1. Guidance Occupancy seen north of 50% next year; hospital and pharma growth at minimum 15% CAGR long term without significant capex.
  2. Tax change Moved to the new tax regime at 25% vs 35% earlier, a recurring benefit to P&L and cash flow.
  3. MedTech Implant business delivered second consecutive positive EBITDA quarter, with FY30 revenue ambition of ₹600-650 cr.
  4. Risk U.S.-Iran conflict hit international patient flow at Gurugram, though CIS and African business partly offset it.

Original filing on BSE

Shalby Limited Q1 FY27 results

As filed: Revenue ₹331 cr (+12% year on year), EBITDA ₹41.6 cr (−1% year on year), PAT ₹10.5 cr (+31% year on year), EBITDA margin 12.6% (−163 bps).

The Q1 FY27 score, against the company's own trend, is for premium members.

Earlier results and the share price after them

  • Q4 FY26: Revenue ₹287 cr (+8% year on year), EBITDA ₹29.4 cr (+40% year on year), PAT ₹18.5 cr, EBITDA margin 10.2% (+229 bps). Score 47 of 100, In line with trend. Revenue growth was below the company's own trend; EBITDA growth was well above it. EBITDA margin rose 229 bps year on year. Other income 84% of PBT. Tax rate -92%. Share price after the results: −0.1% in 29 days (Nifty 500: +0.6%).
  • Q3 FY26: Revenue ₹272 cr (−1% year on year), EBITDA ₹30.3 cr (−11% year on year), PAT ₹1.3 cr, EBITDA margin 11.1% (−120 bps). Score 20 of 100, Below trend. Revenue growth was well below the company's own trend; EBITDA growth was below it. EBITDA margin fell 120 bps year on year. Other income 78% of PBT. Tax rate 86%. Revenue fell 5% from last quarter. Share price after the results: −19.8% in 30 days (Nifty 500: −10.1%).
  • Q2 FY26: Revenue ₹285 cr (+6% year on year), EBITDA ₹42.0 cr (+27% year on year), PAT ₹7.0 cr (+250% year on year), EBITDA margin 14.7% (+242 bps). Score 59 of 100, In line with trend. Revenue growth was below the company's own trend; EBITDA growth was above it; profit growth was well above it. EBITDA margin rose 242 bps year on year. Tax rate 63%. Revenue fell 4% from last quarter. Revenue rose ₹17.0 cr on a year ago, against ₹30.0 cr the year before. Share price after the results: −16.0% in 29 days (Nifty 500: −0.4%).
  • Q1 FY26: Revenue ₹296 cr (+6% year on year), EBITDA ₹42.0 cr (−5% year on year), PAT ₹8.0 cr (−47% year on year), EBITDA margin 14.2% (−158 bps). Score 26 of 100, Below trend. Revenue growth was well below the company's own trend; EBITDA growth was in line with it; profit growth was below it. EBITDA margin fell 158 bps year on year. Other income 30% of PBT. Tax rate 65%. Revenue rose ₹17.0 cr on a year ago, against ₹44.0 cr the year before. Share price after the results: +8.7% in 30 days (Nifty 500: +2.2%).
  • Q4 FY25: Revenue ₹265 cr (+9% year on year), EBITDA ₹21.0 cr (−46% year on year), PAT −₹12.0 cr (−175% year on year), EBITDA margin 7.9% (−806 bps). Score 20 of 100, Below trend. Revenue, EBITDA and profit growth were well below the company's own trend. EBITDA margin fell 806 bps year on year. Revenue fell 4% from last quarter. Revenue rose ₹21.0 cr on a year ago, against ₹45.0 cr the year before. Share price after the results: −7.4% in 29 days (Nifty 500: +3.3%).
  • Q3 FY25: Revenue ₹276 cr (+28% year on year), EBITDA ₹34.0 cr (−19% year on year), PAT −₹3.0 cr (−116% year on year), EBITDA margin 12.3% (−713 bps). Score 20 of 100, Below trend. Revenue growth was well above the company's own trend; EBITDA growth was below it; profit growth was well below it. EBITDA margin fell 713 bps year on year. Other income 42% of PBT. Tax rate 125%. Profit fell 250% from last quarter.
  • Q2 FY25: Revenue ₹268 cr (+13% year on year), EBITDA ₹33.0 cr (−38% year on year), PAT ₹2.0 cr (−93% year on year), EBITDA margin 12.3% (−996 bps). Score 9 of 100, Below trend. EBITDA margin fell 996 bps year on year. Other income 50% of PBT. Tax rate 79%. Not enough history for a trend yet: scored on growth alone. Revenue fell 4% from last quarter.

Past price moves after results do not indicate future moves. Not a recommendation.

Shalby Limited earnings call, investor presentation and press release summaries

Figures from the company's filings with NSE and BSE. Not investment advice.